PAAMC HK Lists Ping An AI Select ETF and Ping An Healthcare 50 Select ETF on SEHK

HONG KONG, Sept. 30, 2026 /PRNewswire/ — Ping An of China Asset Management (Hong Kong) Company Limited ("PAAMC HK" or the "Company" ), the offshore asset management platform of Ping An Insurance (Group) Company of China, Ltd. ("Ping An Group"), is pleased to announce that the Company launches two exchange-traded funds (ETFs) – Ping An AI Select ETF (HKD Counter: 03510/ USD Counter: 41510) and Ping An Healthcare 50 Select ETF (HKD Counter: 03500/ USD Counter: 41500) listed on the Stock Exchange of Hong Kong ("SEHK") today.

Ping An AI Select ETF aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive G2 Artificial Intelligence Select Index NTR, a net total return, free float market capitalisation weighted index that provides exposure to AI companies listed in Hong Kong and the United States that meet defined liquidity requirements. Its components span three key segments of the AI value chain: AI infrastructure, AI platforms, and AI applications. Its investment universe is constructed through a multi-dimensional screening process and dynamically updated to reflect global AI technology trends.

The Ping An Healthcare 50 Select ETF (03500 (HKD counter) / 41500 (USD counter)) aims to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive G2 Healthcare 50 Select Index NTR, a net total return, free-float market capitalization-weighted index providing exposure to 50 leading healthcare companies listed in Hong Kong and the United States. Through its constituents, the Index offers access to investment opportunities across the healthcare value chain, from technology R&D to commercialization channels, covering key areas driving pharmaceutical and biotechnology innovation.

"Following our three existing ETFs eligible for Southbound trading under Stock Connect, we are launching two growth-themed ETFs in response to investor demand." said Mr. Albert Wang, Head of Capital Markets and CIO of PAAMC HK, "As technological breakthroughs drive growth across the AI value chain, the Ping An AI Select ETF spans AI infrastructure, platforms and applications, diversifying exposure across technological pathways while capturing innovation-led opportunities. The Ping An Healthcare 50 Select ETF focuses on Chinese pharmaceutical companies spearheading global expansion and U.S. leaders in innovative medicines, offering one-stop access to the sector’s long-term global growth potential."

With a focus on product innovation, PAAMC HK offers ETFs designed to provide investors with transparent, consistent and low-cost passive investment tools. By delivering premium allocation solutions during Asian trading hours, PAAMC HK seeks to better serve clients across markets and further enrich Hong Kong’s capital market product ecosystem.

Table 1: Key fund facts

END

About Ping An of China Asset Management (Hong Kong) Company Limited

Ping An of China Asset Management (Hong Kong) Company Limited was established in 2006. It is a direct subsidiary of China Ping An Insurance Overseas (Holdings) Limited and a wholly owned subsidiary of Ping An Insurance (Group) Company of China, Ltd. (2318.HK and 601318.SH). It is licensed by the Securities and Futures Commission of Hong Kong ("SFC") to conduct Type 1 (Dealing in Securities), Type 4 (Advising on Securities) and Type 9 (Asset Management) regulated activities. With strong capabilities in investment research and asset management, PAAMC HK is a leading provider of global investment management solutions in equities, fixed income, ETF, structured products and alternative assets. For more information, please visit PAAMC HK’s website (asset.pingan.com.hk). (This website has not been reviewed by the SFC).

Disclaimer

This press release is issued by PAAMC HK. This press release is not an offer in relation to any investment. Investments involve risks. Past performance of any products referenced in this press release (the "Product") does not guarantee future returns. Due to market volatility, the Product is subject to market value fluctuation and the risk of loss of principal. Investors should read the Product’s offering documents carefully for further details including the risk factors and consider their own financial conditions and the Product’s risk situations before making any investment decision. If in doubt, please seek independent financial and professional advice. Please visit PAAMC HK’s website for the relevant offering documents. This press release and PAAMC HK’s website have not been reviewed by the SFC.

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network